These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis. Shen H, Chen W, Conlan JW. Microb Pathog; 2004 Aug 05; 37(2):107-10. PubMed ID: 15312850 [Abstract] [Full Text] [Related]
25. Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy. Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W. PLoS One; 2010 Oct 12; 5(10):e13349. PubMed ID: 20967278 [Abstract] [Full Text] [Related]
26. Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Elkins KL, Cowley SC, Bosio CM. Microbes Infect; 2003 Feb 12; 5(2):135-42. PubMed ID: 12650771 [Abstract] [Full Text] [Related]
28. Identification of a live attenuated vaccine candidate for tularemia prophylaxis. Mahawar M, Rabadi SM, Banik S, Catlett SV, Metzger DW, Malik M, Bakshi CS. PLoS One; 2013 Feb 12; 8(4):e61539. PubMed ID: 23613871 [Abstract] [Full Text] [Related]
30. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice. Quarry JE, Isherwood KE, Michell SL, Diaper H, Titball RW, Oyston PC. Vaccine; 2007 Mar 01; 25(11):2011-8. PubMed ID: 17241711 [Abstract] [Full Text] [Related]
31. Mouse model of oral infection with virulent type A Francisella tularensis. KuoLee R, Zhao X, Austin J, Harris G, Conlan JW, Chen W. Infect Immun; 2007 Apr 01; 75(4):1651-60. PubMed ID: 17242058 [Abstract] [Full Text] [Related]
32. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background. Chen W, Shen H, Webb A, KuoLee R, Conlan JW. Vaccine; 2003 Sep 08; 21(25-26):3690-700. PubMed ID: 12922099 [Abstract] [Full Text] [Related]
33. Francisella tularensis type B ΔdsbA mutant protects against type A strain and induces strong inflammatory cytokine and Th1-like antibody response in vivo. Straskova A, Spidlova P, Mou S, Worsham P, Putzova D, Pavkova I, Stulik J. Pathog Dis; 2015 Nov 08; 73(8):ftv058. PubMed ID: 26253078 [Abstract] [Full Text] [Related]